Reference priceBRL R$28.60Original source price: INR 440.00. Converted estimates are available by currency selection.
| Brand | Mavyret |
|---|---|
| Manufacturer | AbbVie Inc |
| Prescription required | Yes |
Mavyret 50mg/20mg oral pellets,1 x 28packet (glecaprevir/pibrentasvir)
glecaprevir/pibrentasvir
Description
Mavyret 50mg/20mg oral pellets,1 x 28packet(/) (glecaprevir/pibrentasvir) is a medicine catalog record in the MediPriceHub database. Active ingredient: glecaprevir/pibrentasvir. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: AbbVie Inc. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis C drugs. Pack information: 50 / 20 28. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
Glecaprevir with pibrentasvir is a direct-acting antiviral combination used to treat chronic hepatitis C virus infection across multiple genotypes, with regimen details depending on cirrhosis status, prior treatment, renal function, and the approved local label.How to Use
Use glecaprevir/pibrentasvir under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: glecaprevir/pibrentasvir. Pack size: 50 / 20 28. Pack unit: box. Manufacturer: AbbVie Inc. Origin country: United States. Source category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis C drugs. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.Esta informação é apenas para referência. Consulte um profissional de saúde antes de usar qualquer medicamento.